Cigna Group (NYSE:CI – Get Free Report) was upgraded by equities researchers at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday, MarketBeat.com reports. The firm currently has a $358.00 price objective on the health services provider’s stock. Sanford C. Bernstein’s price target indicates a potential upside of 37.28% from the stock’s previous close.
Several other research analysts have also issued reports on CI. Leerink Partners increased their price objective on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Robert W. Baird decreased their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. UBS Group reiterated a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Finally, Truist Financial lifted their target price on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $333.11.
Check Out Our Latest Research Report on CI
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.
Insider Transactions at Cigna Group
In other news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.
Institutional Investors Weigh In On Cigna Group
Several hedge funds have recently added to or reduced their stakes in CI. Mirae Asset Global Investments Co. Ltd. increased its position in Cigna Group by 11.7% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after acquiring an additional 4,738 shares during the period. Maj Invest Holding A S boosted its holdings in Cigna Group by 2.4% in the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after purchasing an additional 10,042 shares during the period. Providence Capital Advisors LLC grew its position in shares of Cigna Group by 1,016.8% during the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after purchasing an additional 7,748 shares in the last quarter. National Pension Service increased its holdings in shares of Cigna Group by 3.2% during the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after purchasing an additional 21,203 shares during the period. Finally, SCS Capital Management LLC raised its position in shares of Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after buying an additional 8,609 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Is Trump Done? Shocking leak…
- The gold chart Wall Street is terrified of…
- The Market Just Split in Two (URGENT)
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
